Publications by authors named "Mevlut Hamamcı"
Intragastric injection of botulinum toxin in the treatment of obesity: a single-center study.
Ther Adv Gastrointest Endosc
March 2024
Background: In recent years, various novel surgical and non-surgical therapeutic options have been developed for treating obesity. Due to its disputed success, intragastric botulinum toxin A (BTX-A) injection is still being debated.
Objectives: We aim to contribute to this controversial issue in the literature by sharing our center's findings regarding intragastric BTX-A injections in the treatment of obesity.
Article Synopsis
- Acute pancreatitis is increasingly common and severe among older adults, especially those over 80 years of age.
- A study analyzed 1150 patients with acute pancreatitis, finding that octogenarians had significantly higher rates of severe cases and complications compared to younger groups.
- Mortality rates were dramatically higher in older patients, with about 50% of those over 80 years old dying from the condition, unlike just 1.1% in the younger group.
Background: Many rheumatic diseases may cause gastrointestinal manifestations. The goal of this study was to analyze the prevalence and predictors of gastrointestinal involvement in patients with rheumatic disorders.
Methods: A retrospective chart review was performed for patients with systemic lupus erythematosus, rheumatoid arthritis, and sys- temic sclerosis who have consulted due to gastrointestinal symptoms.
Article Synopsis
- Crohn's disease (CD) involves ongoing inflammation of the gastrointestinal tract, often needing imaging tests for assessment.
- The study aimed to compare the effectiveness of intestinal ultrasound (IUS) and magnetic resonance enterography (MRE) in measuring CD activity, using a simple endoscopic score as a benchmark.
- Both IUS and MRE performed similarly for detecting general activity, but MRE was better at identifying certain lesions, while IUS showed higher specificity and sensitivity for ascites, suggesting it may be a better option for monitoring CD.
Article Synopsis
- HCC (Hepatocellular Carcinoma) is the most frequent primary liver tumor and requires high-risk HBV carriers to undergo surveillance through ultrasound every 6-12 months as per AASLD guidelines.
- The serum α-fetoprotein level is used for diagnosing HCC but can also be elevated in other conditions like acute hepatitis, cirrhosis, and various cancers, which complicates the diagnosis.
- Clinicians must be cautious and consider other potential causes for elevated α-fetoprotein levels when assessing patients with liver masses, particularly in those with HBV-related cirrhosis.
Background: Dieulafoy's lesion (DL) is a relatively uncommon medical condition characterized by a large tortuous arteriole in the submucosa of any part of gastrointestinal (GI) tract wall that bleeds via erosion likely caused in the submucosal surface by protrusion of the pulsatile arteriole. Compared with other endoscopic hemostatic techniques, clipping alone for DL is limited.
Aims: The aim of the present case series study is to identify common clinical and endoscopic features, rates of occurrence, to review the outcome of endoscopic management of upper GI tract DL, and to illustrate the use and the efficiency of endoclips in maintaining the GI bleeding due to DL.
Colorectal cancer (CRC) is the third most common cause of cancer-related death in Europe. The aim of the present study was to elucidate the efficiency of the neutrophil/lymphocyte ratio (NLR), the platelet/lymphocyte ratio (PLR), and the mean platelet volume (MPV) as tools for the preoperative diagnosis of CRC and their usefulness in the follow-up of CRC. A total of 144 CRC patients, as diagnosed by colonoscopy, and 143 age-matched and sex-matched healthy participants were included in the study.
View Article and Find Full Text PDFBackground: The values of C-reactive protein (CRP) can prove useful in determining disease progress. Because of synthesis by the liver, production of CRP in response to inflammation may be attenuated in patients with liver dysfunction. This may result in differences interpreting CRP levels in patient with portal and non-portal hypertension ascites.
View Article and Find Full Text PDF